Cleveland Clinic Cancer Center highlights top 10 abstracts to watch for at ASTRO 2023.Read More
Cleveland Clinic physician shares case of a patient with advanced triple-negative breast cancer achieving a durable response to 4th line therapy.
Palliative medicine specialist Laura Shoemaker, DO, believes that it’s key for physicians to begin a difficult conversation by finding out what the patient knows about their condition. “Ask what they’ve been told and what their understanding of that is. Find out what’s most important to them.”
Non-covalent BTK inhibitor found effective in some heavily pretreated patients with CLL.
Numerous cancer treatments have been shown to have side effects such as ocular toxicities.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Pediatric oncologist Seth Rotz, MD, says that when he has difficult news to share with a patient and their family, “I feel obliged to tell them as soon as it’s safe to tell them.”
Cancer metastasis to the eye can manifest as ocular motility issues, blurry vision, and sunken or bulging eyes. Ophthalmologists can contribute to prompt diagnosis and treatment to improve a patient’s quality of life.
Two-day CME program highlights the latest diagnostic and treatment options for colorectal cancer.
A recent study uncovered risk factors for venous thromboembolism among patients with multiple myeloma post autologous hematopoietic cell transplant.
Intracoronary brachytherapy is a safe and feasible, albeit imperfect, option for treating recurrent drug-eluting stent in-stent restenosis, a new Cleveland Clinic retrospective analysis finds.
Next-generation sequencing may improve upon existing methods for measuring minimal residual disease in patients with AML or myelodysplastic syndrome who have received a allogeneic hematopoietic stem cell transplant.